Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pivotal Health Sciences is a Canada-based nanobiotechnology company operating from Moncton, New Brunswick. The business was incorporated in 2020 as Pivotal Health Sciences and later changed its legal name to Pividl Bioscience, while continuing to be referenced publicly under the Pivotal Health Sciences name. The company develops proprietary clean technologies for extracting, encapsulating, and formulating bioactive compounds from plant, fungal, and marine sources. Its platform is positioned for cross-sector applications spanning human and animal health, nutraceuticals, cosmetics, agrifood, and pharmaceuticals. Publicly available information suggests the company is focused more on enabling technology and ingredient/product commercialization than on a conventional therapeutic clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pivotal Health Sciences.